Press release
Vaccine Adjuvants Market Size in 2023 To 2029 | Dynavax Technologies (US) Croda International plc (UK) GSK plc (UK) Seppic (France) Novavax (US) SPI pharma ( subsidiary of Associated British Foods plc ) (UK) Agenus Inc. (US) Phibro Animal Health Corporati
The Vaccine Adjuvants market report provides an extensive analysis of the vaccine adjuvants market, offering a comprehensive overview of key aspects. It segments the market based on various criteria, including type, end-user/application, product offerings, and geographical regions.๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐ ๐ซ๐๐ ๐๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ + ๐๐๐ญ๐๐ข๐ฅ๐๐ ๐๐๐ โก๏ธ https://www.reportsnreports.com/contacts/requestsample.aspx?name=597366
๐๐๐๐๐ข๐ง๐ ๐ฉ๐ฅ๐๐ฒ๐๐ซ๐ฌ ๐ฉ๐ซ๐จ๐๐ข๐ฅ๐๐ ๐ข๐ง ๐ญ๐ก๐ข๐ฌ ๐ซ๐๐ฉ๐จ๐ซ๐ญ
Dynavax Technologies (US) Croda International plc (UK) GSK plc (UK) Seppic (France) Novavax (US) SPI pharma ( subsidiary of Associated British Foods plc ) (UK) Agenus Inc. (US) Phibro Animal Health Corporation (US) Aurorium (Vertellus) (US) Merck KGaA (Germany) Vaxine Pty Ltd. (Australia) Hawaii Biotech Inc. (US) CSL Limited (Australia) OZ Biosciences (US) InvivoGen (US) Allergy Therapeutics (UK) EuBiologics Co., Ltd. (South Korea) Pacific GeneTech Limited (US) Riboxx GmbH (Germany) CaPtivate Pharmaceuticals LLC (US) Creative Diagnostics (US) LiteVax BV (Netherlands) Mukta Industries (India) Oncovir, Inc. (US) TiterMax USA, Inc. (US).
This report extends its global reach, with a primary focus on regions like Asia Pacific, Europe, North America, Latin America, the Middle East, and Africa. Furthermore, it delves into the specifics of country-wise markets, encompassing emerging economies such as India, China, the United States, the United Kingdom, France, Germany, Japan, and more.
The Vaccine Adjuvants market report also highlights the latest technological advancements within the industry, empowering buyers to stay updated on the market's most recent developments. Stakeholders can gain insights into the market's dynamics, including valuable approximations of market size, revenue shares, and current trends.
Additionally, the report offers valuable data on market drivers, restraints, challenges, and opportunities, providing a comprehensive understanding of the industry's behavior. It outlines a forward-looking trajectory that can guide companies and other stakeholders in making informed decisions for sustained profitability in the years to come. This report presents a practical overview of the global Vaccine Adjuvants market and its evolving landscape, aiding readers in making informed choices regarding their market ventures. The primary focus of this report is on growth opportunities that enable the market to expand its operations within existing markets.
"The vaccine adjuvants market is projected to grow at a CAGR of 6.9% during the forecast period of 2023-2028."
The global vaccine adjuvants market size is projected to reach USD 1.2 billion by 2028 from USD 0.8 billion in 2023, at a CAGR of 6.9% during the forecast period. Factors such as as the rising prevalence of infectious diseases, increasing number of vaccines under clinical trials, and increasing focus on immunization programs are likely to have positive impact on the market growth.
"The adjuvant emulsions segment held the dominant share in the vaccine adjuvants market"
Based on product, the global vaccine adjuvants market is segmented into pathogen component, adjuvant emulsions, particulate adjuvants, saponin-based adjuvants and other adjuvants. The adjuvant emulsions segment held a dominant share in the market in 2022. Extensive use of adjuvant emulsions in COVID-19 & other infectious diseases and the rising prevalence of contagious diseases are likely to have positive impact on the growth of the market.
"infectious disease segment accounted for the largest share of the disease type segment in 2022."
Based on disease type, the vaccine adjuvants market is segmented into infectious diseases, cancer and other diseases. In 2022, the infectious disease segment accounted for the largest share of the vaccine adjuvants market. The segment held the dominant share in the market owing to various factors such as increasing prevalence of infectious diseases and the rising demand for new adjuvanted vaccines for infectious diseases such as influenza.
โก๏ธ ๐๐ง๐ช๐ฎ๐ข๐ซ๐ ๐ ๐จ๐ซ ๐๐จ๐ซ๐ ๐๐ง๐๐จ๐ซ๐ฆ๐๐ญ๐ข๐จ๐ง @https://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=597366
Research Coverage:
This report provides a detailed picture of the vaccine adjuvants market. It aims at estimating the size and future growth potential of the market across different segments, such as product, route of administration, disease type, application, type and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall vaccine adjuvants market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Vaccine Adjuvants Market Size in 2023 To 2029 | Dynavax Technologies (US) Croda International plc (UK) GSK plc (UK) Seppic (France) Novavax (US) SPI pharma ( subsidiary of Associated British Foods plc ) (UK) Agenus Inc. (US) Phibro Animal Health Corporati here
News-ID: 3246320 • Views: โฆ
More Releases from ReportsnReports

DeviceCon Series 2024 - UK Edition | MarketsandMarkets
Future Forward: Redefining Healthcare with Cutting-Edge Devices
Welcome to DeviceCon Series 2024 - Where Innovation Meets Impact!
Join us on March 21-22 at Millennium Gloucester Hotel, 4-18 Harrington Gardens, London SW7 4LH for a groundbreaking convergence of knowledge, ideas, and technology. MarketsandMarkets proudly presents the DeviceCon Series, an extraordinary blend of four conferences that promise to redefine the landscape of innovation in medical and diagnostic devices.
Register Now @ https://events.marketsandmarkets.com/devicecon-series-uk-edition-2024/register
MarketsandMarkets presentsโฆ

5th Annual MarketsandMarkets Infectious Disease and Molecular Diagnostics Confer โฆ
London, March 7, 2024 - MarketsandMarkets is thrilled to announce the eagerly awaited 5th Annual Infectious Disease and Molecular Diagnostics Conference, scheduled to take place on March 21st - 22nd, 2024, at the prestigious Millennium Gloucester Hotel, located at 4-18 Harrington Gardens, London SW7 4LH.
This conference promises to be a groundbreaking event, showcasing the latest trends and insights in diagnosis, as well as unveiling cutting-edge technologies that are revolutionizing theโฆ

Infection Control, Sterilization & Decontamination Conference |21st - 22nd March โฆ
MarketsandMarkets is pleased to announce its 8th Annual Infection Control, Sterilisation, and Decontamination in Healthcare Conference, which will take place March 21-22, 2024, in London, UK. With the increased risk of infection due to improper sterilisation and decontamination practices, the safety of patients and healthcare workers is of paramount importance nowadays.
Enquire Now @ https://events.marketsandmarkets.com/infection-control-sterilization-and-decontamination-conference/
This conference aims to bring together all the stakeholders to discuss the obstacles in achievingโฆ

Breast Augmentation Market Key Players, Demands, Cost, Size, Procedure, Shape, S โฆ
The global Breast Augmentation Market in terms of revenue was estimated to be worth $900 million in 2020 and is poised to reach $1,692 million by 2025, growing at a CAGR of 13.4% from 2020 to 2025. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buyingโฆ
More Releases for Vaccine
Flu Vaccine (Influenza Vaccine) Market: A look into the future of the โUnivers โฆ
Latest update on Flu Vaccine (Influenza Vaccine) Market Analysis Report published with an SMI, the industry growth analysis, and Projection by 2021-2028. This report is highly predictive as it holds the overall market analysis of the topmost companies in the Flu Vaccine (Influenza Vaccine) industry. With the classified Flu Vaccine (Influenza Vaccine) market research based on various growing regions, this report provides leading players' portfolios along with sales, growth, marketโฆ
Vaccine Market
Rise in the prevalence of infectious diseases, increase in immunization programs across the globe, and surge in R&D activities to develop new vaccine drive the growth of the global vaccine market.
Global Vaccines Market was pegged at $32.46 billion in 2019, and is anticipated to hit $54.15 billion by 2027, registering a CAGR of 6.6% from 2020 to 2027. The report provides an in-depth analysis of the top investment pockets, topโฆ
US Flu Vaccine [Influenza Vaccine] Market Research Report 2020
DPI Research offers a latest published report on โInfluenza Vaccines in the United States โ Market Size, Trends, Opportunities and Growth Potentialโ delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key US flu vaccines market players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyzeโฆ
Measles Vaccine
Measles Vaccine Market describes its growth, size, share, Forecast and trends to 2025
Measles Vaccine Market Production and Demand Analysis 2019 to 2025
Measles Vaccine Market 2019 Manufacturing Analysis and Development Forecast 2025
Measles Vaccine Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025
Measles Vaccine Market to Insight By 2025: Top Key Vendors
The global Measles Vaccine market is valued at million US$ in 2018 and will reach million US$ by theโฆ
Monovalent vaccine segment to accumulate maximum Paediatric Vaccine Market share
According to a new report published by Future Market Insights titled โPaediatric Vaccine Market: Global Industry Analysis & Opportunity Assessment, 2016 โ 2026โ, in terms of revenue, the global paediatric vaccine market is expected to increase at 12.2% CAGR during the forecast period 2016-2026. The global paediatric vaccine market is expected to reach US$ 27.97 Bn in 2016.
Paediatric vaccine market is a billion dollar market accounting for a substantial proportionโฆ
Key Tools for Innovative Vaccine Designs: Vaccine Adjuvants
The report โNORTH AMERICA VACCINE ADJUVANTS MARKETโ provides the detail description of market segmentation, applications, growth, size, and outlook. The market is projected to reach USD $278 Million by 2024, at a CAGR of 11.3%.
An adjuvant is an immunological agent, which modifies the effect of other agents. Adjuvants can also act as an irritant, which engages and amplifies the body immune response. Adjuvants are added to vaccines to boost theโฆ